Cargando…

IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation

Graft-versus-host disease (GvHD) remains a major cause of transplant-related mortality. Interleukin-2 (IL-2) plus sirolimus (SIR) synergistically reduces acute GvHD in rodents and promotes regulatory T cells. This phase II trial tested the hypothesis that IL-2 would facilitate STAT5 phosphorylation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Betts, Brian C., Pidala, Joseph, Kim, Jongphil, Mishra, Asmita, Nishihori, Taiga, Perez, Lia, Ochoa-Bayona, Jose Leonel, Khimani, Farhad, Walton, Kelly, Bookout, Ryan, Nieder, Michael, Khaira, Divis K., Davila, Marco, Alsina, Melissa, Field, Teresa, Ayala, Ernesto, Locke, Frederick L., Riches, Marcie, Kharfan-Dabaja, Mohamed, Fernandez, Hugo, Anasetti, Claudio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ferrata Storti Foundation 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477614/ https://www.ncbi.nlm.nih.gov/pubmed/28104702 http://dx.doi.org/10.3324/haematol.2016.153072

Ejemplares similares

In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation
por: Pidala, Joseph, et al.
Publicado: (2018)

Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemia
por: Pidala, Joseph, et al.
Publicado: (2010)

A phase 2 multicenter trial of ofatumumab and prednisone as initial therapy for chronic graft-versus-host disease
por: Lazaryan, Aleksandr, et al.
Publicado: (2022)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
por: Rafei, Hind, et al.
Publicado: (2017)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2023)

Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma
por: Logue, Jennifer M., et al.
Publicado: (2020)

P1540: COVID-19 INFECTION AMONG CAR-T CELL THERAPY RECIPIENTS: A SINGLE CENTER EXPERIENCE
por: Din, Mohammad Ammad Ud, et al.
Publicado: (2023)

Comparative efficacy of tandem autologous versus autologous followed by allogeneic hematopoietic cell transplantation in patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials
por: Kharfan-Dabaja, Mohamed A, et al.
Publicado: (2013)

Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
por: Ionescu, Filip, et al.
Publicado: (2022)

Fine-tuning alloreactivity against HLA-DP to control leukemia with tolerable graft-versus-host disease
por: Pidala, Joseph, et al.
Publicado: (2022)

Voriconazole Provides Effective Prophylaxis for Invasive Fungal Infection in Patients Receiving Glucocorticoid Therapy for Graft-Versus-Host Disease
por: Gergis, Usama, et al.
Publicado: (2009)

P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO-HCT
por: Albanyan, O., et al.
Publicado: (2022)

Transplanters drive CARs to the clinic by brewing ICE-T: the Moffitt roadmap
por: Locke, Frederick L., et al.
Publicado: (2017)

Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL
por: Perez, Ariel, et al.
Publicado: (2022)

CAR T-cell therapy for follicular lymphoma and mantle cell lymphoma
por: Mohty, Razan, et al.
Publicado: (2022)

PB2092: INCIDENCE AND RISK FACTORS ASSOCIATED WITH BLEEDING FOLLOWING ANTI-B CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Mohammed, Turab, et al.
Publicado: (2023)

Recent advances in immunotherapy for B-cell non-Hodgkin lymphoma and multiple myeloma
por: Chavez, Julio C., et al.
Publicado: (2022)

Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
por: Nishihori, Taiga, et al.
Publicado: (2017)

Controversies and Recent Advances in Hematopoietic Cell Transplantation for Follicular Non-Hodgkin Lymphoma
por: Kanate, Abraham S., et al.
Publicado: (2012)

Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies
por: Kharfan-Dabaja, Mohamed A., et al.
Publicado: (2019)

Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
por: Perez, Lia Elena, et al.
Publicado: (2016)

CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
por: Chavez, Julio C., et al.
Publicado: (2019)

Axicabtagene Ciloleucel in the Management of Follicular Lymphoma: Current Perspectives on Clinical Utility, Patient Selection and Reported Outcomes
por: Mohty, Razan, et al.
Publicado: (2023)

Tolerance Associated Gene Expression following Allogeneic Hematopoietic Cell Transplantation
por: Pidala, Joseph, et al.
Publicado: (2015)

Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity
por: Betts, Brian C., et al.
Publicado: (2018)

Tregs combined with mature donor T cells hasten immune reconstitution without triggering GvHD in HLA haploidentical transplantation
por: Di Ianni, Mauro, et al.
Publicado: (2011)

Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis
por: Riches, Marcie L., et al.
Publicado: (2015)

Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
por: Nishihori, Taiga, et al.
Publicado: (2016)

Cytokine Release Syndrome: Current Perspectives
por: Murthy, Hemant, et al.
Publicado: (2019)

Cardiac and inflammatory biomarker differences in adverse cardiac events after chimeric antigen receptor T-Cell therapy: an exploratory study
por: Lee, Dae Hyun, et al.
Publicado: (2023)

Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions
por: Chavez, Julio C, et al.
Publicado: (2021)

Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma
por: Locke, Frederick L, et al.
Publicado: (2015)

BACTERIAL BLOOD STREAM INFECTIONS (BSI), PARTICULARLY POST-ENGRAFTMENT BSI, ARE ASSOCIATED WITH INCREASED MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
por: Ustun, Celalettin, et al.
Publicado: (2018)

Immunotherapy beyond cellular therapy in follicular lymphoma: A case of complete remission after failure of two CAR‐T
por: Kase, Adam M., et al.
Publicado: (2022)

The Evolution of Our Understanding of Immunoproliferative Small Intestinal Disease (IPSID) over Time
por: AlYamany, Ruah, et al.
Publicado: (2022)

Association of Patient-Reported Physical Activity on Allogeneic Hematopoietic Cell Transplant Outcomes
por: Jayani, Reena V., et al.
Publicado: (2021)

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis
por: Epperla, Narendranath, et al.
Publicado: (2019)

Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myeloma
por: Logue, Jennifer M., et al.
Publicado: (2022)

Distribución y Abundancia de aves marinas en el Parque Nacional Sistema Arrecifal Veracruzano, con relación a variables abióticas :
por: Herrera Alsina, Leonel Salatiel
Publicado: (2009)

Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population
por: Kharfan-Dabaja, Mohamed A., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_nl4r33spvdapvd6geha6ikaq6s